NO865012D0 - Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater.

Info

Publication number
NO865012D0
NO865012D0 NO865012A NO865012A NO865012D0 NO 865012 D0 NO865012 D0 NO 865012D0 NO 865012 A NO865012 A NO 865012A NO 865012 A NO865012 A NO 865012A NO 865012 D0 NO865012 D0 NO 865012D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutic active
benzazepine derivatives
active benzazepine
Prior art date
Application number
NO865012A
Other languages
English (en)
Other versions
NO168820B (no
NO168820C (no
NO865012L (no
Inventor
Jagabandhu Das
David Mack Floyd
John Krapcho
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NO865012D0 publication Critical patent/NO865012D0/no
Publication of NO865012L publication Critical patent/NO865012L/no
Publication of NO168820B publication Critical patent/NO168820B/no
Publication of NO168820C publication Critical patent/NO168820C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO865012A 1985-12-12 1986-12-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater NO168820C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80818385A 1985-12-12 1985-12-12
US91713086A 1986-10-09 1986-10-09

Publications (4)

Publication Number Publication Date
NO865012D0 true NO865012D0 (no) 1986-12-11
NO865012L NO865012L (no) 1987-06-15
NO168820B NO168820B (no) 1991-12-30
NO168820C NO168820C (no) 1992-04-08

Family

ID=27123095

Family Applications (1)

Application Number Title Priority Date Filing Date
NO865012A NO168820C (no) 1985-12-12 1986-12-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater

Country Status (18)

Country Link
EP (1) EP0229329B1 (no)
JP (1) JPH0686435B2 (no)
KR (1) KR900001177B1 (no)
CN (1) CN1017894B (no)
AU (1) AU591726B2 (no)
CA (2) CA1271748A (no)
CZ (1) CZ278686B6 (no)
DE (1) DE3688788T2 (no)
DK (1) DK163731C (no)
ES (1) ES2058059T3 (no)
FI (1) FI83775C (no)
HU (2) HU196760B (no)
IE (1) IE61757B1 (no)
IL (2) IL80668A0 (no)
NO (1) NO168820C (no)
NZ (1) NZ218292A (no)
PL (2) PL151569B1 (no)
PT (1) PT83917B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752645A (en) * 1986-10-09 1988-06-21 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4771047A (en) * 1987-07-27 1988-09-13 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4774239A (en) * 1987-08-26 1988-09-27 E. R. Squibb & Sons, Inc. Benzazepine derivatives
DE3807922A1 (de) * 1988-03-10 1989-09-21 Boehringer Mannheim Gmbh Substituierte heterocyclen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
US4902684A (en) * 1988-06-20 1990-02-20 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
AU2001218083A1 (en) * 2000-01-26 2001-08-07 Warner Lambert Company Ace inhibitor-vasopressin antagonist combinations
US20030008860A1 (en) 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
JP2022055368A (ja) * 2019-02-19 2022-04-08 株式会社三和化学研究所 ベンゾアゼピン誘導体の製造方法及びその中間体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3075967A (en) 1961-06-12 1963-01-29 Olin Mathieson Benzothiazines
US3330823A (en) 1964-12-16 1967-07-11 Squibb & Sons Inc N-amino-loweralkylene-benzo-lactams
CA1271747A (en) 1985-06-12 1990-07-17 David M. Floyd Benzazepines derivatives

Also Published As

Publication number Publication date
NO168820B (no) 1991-12-30
JPS62164668A (ja) 1987-07-21
IE863224L (en) 1988-04-09
CN86108530A (zh) 1987-06-17
DE3688788D1 (de) 1993-09-02
HU199806B (en) 1990-03-28
FI83775B (fi) 1991-05-15
FI83775C (fi) 1991-08-26
FI865056A (fi) 1987-06-13
EP0229329A1 (en) 1987-07-22
CA1271748C (en) 1990-07-17
KR870005999A (ko) 1987-07-08
IL95607A0 (en) 1991-06-30
DK595686D0 (da) 1986-12-11
HUT43572A (en) 1987-11-30
EP0229329B1 (en) 1993-07-28
NO168820C (no) 1992-04-08
HU196760B (en) 1989-01-30
DE3688788T2 (de) 1994-03-03
KR900001177B1 (ko) 1990-02-27
CA1271748A (en) 1990-07-17
IE61757B1 (en) 1994-11-30
PT83917B (en) 1988-06-23
ES2058059T3 (es) 1994-11-01
AU591726B2 (en) 1989-12-14
PL151569B1 (en) 1990-09-28
CN1017894B (zh) 1992-08-19
PL262928A1 (en) 1988-08-04
CZ278686B6 (en) 1994-05-18
PT83917A (en) 1987-01-01
DK163731C (da) 1992-08-31
PL271723A1 (en) 1988-12-08
PL150461B1 (en) 1990-05-31
JPH0686435B2 (ja) 1994-11-02
DK595686A (da) 1987-06-13
NZ218292A (en) 1988-10-28
CA1294617C (en) 1992-01-21
DK163731B (da) 1992-03-30
FI865056A0 (fi) 1986-12-11
IL80668A0 (en) 1987-02-27
CZ915486A3 (en) 1994-01-19
AU6530386A (en) 1987-06-18
NO865012L (no) 1987-06-15

Similar Documents

Publication Publication Date Title
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO871266D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO862956L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO884231D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridin-derivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO881762D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO865012D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO853525L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolizinon-derivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.